Home/CureGenetics/Dr. Ren Li
DR

Dr. Ren Li

Chief Technology Officer

CureGenetics

Therapeutic Areas

CureGenetics Pipeline

DrugIndicationPhase
CGC729Relapsed/Refractory Metastatic Clear Cell Renal Cell CarcinomaPhase 1